Company Profile

Public information reviewed
IRONWOOD PHARMACEUTICALS INC logo

IRONWOOD PHARMACEUTICALS INC

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions.

USNASDAQ: IRWD
Public sources
1 reviewed
Published leadership records
18
Last reviewed
Sep 14, 2026
View sources

Company overview

Business, legal identity, ownership structure and classifications.

What the company does

About

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the

Sector and industry values retain their source labels. A classification provider, taxonomy version and assignment date are not established unless the cited record states them.

Stable business record

Identity and status

Ownership and listing state

Public listing published

Ownership not asserted

The canonical public record includes at least one active security listing.

Inspect status source
Legal name
IRONWOOD PHARMACEUTICALS INC
Inspect source
Sector
Healthcare
Inspect source
Industry
Drug Manufacturers - Specialty & Generic
Inspect source

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 15, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Governance

Board leadership, management, committees and their disclosed responsibilities.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 14, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

13 public records

Disclosure boundary

Governance and independence

Only current, confirmed leadership roles with public evidence are included in the canonical projection.

RecordStatusAuthorityEffective

Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.

Investors & capital

Ownership, funding and dated financial information.

Ownership disclosures retain their reporting dates and source types. Economic ownership, investment discretion and voting authority are distinct. Activism and settlement-dated short interest are not established by holdings or short-sale volume.

Risk & assurance

Disclosed coverage, ratings and assurance scope.

Credit-rating evidence, where published, appears in the Governance and Basis sections with its source and reporting date. Insurance coverage, cyber ratings and assurance reports require their own issuer, scope, date and usage rights. Indemnification does not establish insurance coverage.

Ecosystem

Published relationships and related records.

Connections

Explore the roles, education and affiliations published in this record.

Alexander Denner

Open Alexander Denner profile →
Alexander DennerAlexander DennerAlexander Denner, …Alexander Denner, Ph.D.Catherine MoukheibirCatherine MoukheibirGregory MartinezGregory MartinezGregory MartiniGregory MartiniJay ShepardJay ShepardJohn MinardoJohn MinardoJon DuaneJon DuaneJulie McHughJulie McHughMark Currie, Ph.D.Mark Currie, Ph.D.Marla KesslerMarla KesslerMichael Shetzline,…Michael Shetzline, M.D., Ph.D.IRONWOOD PHARMACEU…

Dashed lines mark past roles. Select a connection to see its dates and sources.

Basis

Identifiers, sources and record limitations.

Identifiers

Alpha ID
alpha:company:46862e3a-c1fa-4f6c-b6e7-1531dd603a31
Record version
public-1

Sources

Sources and published information

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary.

Open source
State
Published
Source type
canonical_identity
Last reviewed
Sep 14, 2026